Form 4 for TECH Bio-Techne
Accepted 2021-08-13 00:00:00 ET · period of report 2021-08-11 · accession 0000914190-21-000260 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-13 | 2021-08-11 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $108.49 | +921 | 165.1K | +0.6% | +$99.9K |
| D | 2021-08-13 | 2021-08-11 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $0.00 | -921 | 173.9K | -0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-11 | M | A | 921 | $108.49 | 165,114 | D | — | — | (F1) Includes (i) 3,763 shares of restricted stock for which the risk of forfeiture will lapse on August 7, 2022; (ii) 5,724 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2022 and August 5, 2023; and (iii) 5,344 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on August 6, 2022 and as to 1,781 shares on each of August 6, 2023 and August 6, 2024. |
| 2 | Derivative | Stock Options (Right to Buy) | 2021-08-11 | M | D | 921 | $0.00 | 173,942 | D | $108.49 · — to 2022-08-07 | 921 Common Stock | (F2) Fully exercisable. |